Coloplast A/S CLPBF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 429.03M | 328.16M | 605.91M | 537.37M | 593.93M |
| Total Depreciation and Amortization | 649.55M | 188.05M | 182.98M | 176.09M | 179.11M |
| Total Amortization of Deferred Charges | 40.10M | 40.10M | 40.10M | 40.10M | 17.83M |
| Total Other Non-Cash Items | 92.93M | 648.27M | 330.94M | 348.95M | 255.69M |
| Change in Net Operating Assets | -22.46M | -28.53M | -104.32M | -108.11M | -105.18M |
| Cash from Operations | 1.19B | 1.18B | 1.06B | 994.40M | 941.38M |
| Capital Expenditure | -217.38M | -235.46M | -212.93M | -194.68M | -194.79M |
| Sale of Property, Plant, and Equipment | 1.85M | 1.39M | 457.30K | 717.30K | 2.33M |
| Cash Acquisitions | -21.34M | -21.65M | -- | -- | -- |
| Divestitures | 0.00 | 0.00 | 0.00 | 27.44M | 27.44M |
| Other Investing Activities | -27.01M | -27.29M | -20.16M | -20.90M | -24.96M |
| Cash from Investing | -263.88M | -283.02M | -232.63M | -187.42M | -189.99M |
| Total Debt Issued | 2.33B | 3.17B | 3.16B | 2.78B | -274.00M |
| Total Debt Repaid | -3.04B | -3.39B | -3.04B | -3.04B | -289.00M |
| Issuance of Common Stock | 0.00 | 0.00 | 0.00 | 28.00M | 278.00M |
| Repurchase of Common Stock | -- | -- | -1.00M | -1.00M | -1.00M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -804.34M | -803.78M | -803.78M | -718.93M | -718.93M |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -913.48M | -836.97M | -777.91M | -773.65M | -766.78M |
| Foreign Exchange rate Adjustments | 3.03M | -3.52M | -8.13M | -7.26M | -7.76M |
| Miscellaneous Cash Flow Adjustments | 460.60K | 460.60K | -- | -- | 0.00 |
| Net Change in Cash | 15.27M | 53.00M | 36.94M | 26.06M | -23.15M |